On Wednesday August 14, 2024, Alpha Tau Medical Reported Q2 EPS $(0.11) Beats $(0.12) Estimate
Portfolio Pulse from Benzinga Newsdesk
Alpha Tau Medical (NASDAQ:DRTS) reported Q2 EPS of $(0.11), beating the analyst consensus estimate of $(0.12) by 8.33%. This represents an 8.33% improvement over the same period last year.
August 15, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alpha Tau Medical reported Q2 EPS of $(0.11), beating the analyst consensus estimate of $(0.12) by 8.33%. This is an 8.33% improvement over the same period last year.
Beating EPS estimates generally has a positive impact on stock prices as it indicates better-than-expected financial performance. The 8.33% improvement over the same period last year further supports a positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100